🔗 Visit the ClinicalTrials.gov page for NCT01330173
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Unraveling the therapeutic potential of the Hedgehog pathway in cancer. | Nat Med | 2013 | 2.55 |
| 2 | Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. | Nat Rev Clin Oncol | 2015 | 2.02 |
| 3 | Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1. | Am J Hematol | 2013 | 0.96 |
| 4 | Hedgehog signaling in cancer stem cells: a focus on hematological cancers. | Stem Cells Cloning | 2015 | 0.93 |
| 5 | Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies. | J Hematol Oncol | 2014 | 0.91 |
| 6 | Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy. | Expert Rev Mol Med | 2015 | 0.87 |
| 7 | Targeting self-renewal pathways in myeloid malignancies. | Cell Commun Signal | 2013 | 0.87 |
| 8 | Investigational agents in metastatic basal cell carcinoma: focus on vismodegib. | J Exp Pharmacol | 2012 | 0.75 |